Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01801 INNOVENT BIO
RT Nominal up35.800 +0.750 (+2.140%)
Ranking Overview
Buy
Ranking based on 18 research report(s)
Average Ranking 2.11
0
16
2
0
0
Previous Financial Performance
Financial Year 12/2023 EPS -66.00 RMB (cts)
Net Profit -1,027.91 RMB (MIL) DPS 0.00 RMB (cts)
Consolidation Estimation
Financial Year Profit / (Loss)
(RMB (MIL))
EPS/
((LPS)(RMB (cts))
DPS
(RMB (cts))
Net Asset Value per Share
(RMB)
Highest
(RMB (MIL))
Lowest
(RMB (MIL))
2024-797.50-47.600---422.00-1,097.00
202587.005.500--615.00-811.00
20261,425.0091.100--2,358.00197.00
Profit Estimation
Profit Estimation Profit / (Loss)
(RMB (MIL))
EPS*/
(LPS) (RMB (cts))
DPS *
(RMB (cts))
Broker Ranking Target Price*
(HKD)
Update Date
2024-429.00-26.00--CITIC SECBuy70.00 04/11/2024
2024-553.00-35.00--HAITONGOutPerform67.80 02/09/2024
2024-1,097.00-70.00--MORGAN STANLEYOverweight66.50 30/10/2024
2024-660.00-42.40--CITIGROUPBuy62.00 11/09/2024
2024-422.00-26.00--UBSBuy61.40 28/11/2024
2024-767.00-47.20--BOCOMBuy60.00 29/08/2024
2024-940.00-60.30--NOMURABuy58.09 28/08/2024
2024-783.00-48.00--CICCOutPerform58.00 06/11/2024
2024-812.00-53.00--BANK OF AMERICABuy56.40 19/12/2024
2024-940.00-60.30--BOCIBuy56.00 09/07/2024
2024-913.00-56.00--CCBIOutPerform55.50 12/08/2024
2024-731.00-45.00--CMB INT'L SECBuy55.21 05/11/2024
2024-946.00-58.00--HSBCBuy53.00 15/11/2024
2024-819.00-50.00--JP MORGANOverweight50.00 29/10/2024
2024-981.00-37.00--CHINA MERCHANTSBuy49.00 28/10/2024
2024-708.00-43.00--ZHONGTAI INT'L SECBuy42.45 01/11/2024
2024-899.00-55.00--CLSAHold37.30 31/10/2024
2024-629.30-40.00--MACQUARIENeutral37.00 29/10/2024
 
2025354.0022.00--CITIC SEC----04/11/2024
2025-55.00-4.00--HAITONG----02/09/2024
2025-811.00-50.00--MORGAN STANLEY----30/10/2024
2025-165.00-10.60--CITIGROUP----11/09/2024
2025406.0025.00--UBS----28/11/2024
2025358.0022.00--BOCOM----29/08/2024
2025225.0014.46--NOMURA----28/08/2024
2025494.0030.002.00CICC----06/11/2024
202562.004.00--BANK OF AMERICA----19/12/2024
202551.003.30--BOCI----09/07/2024
2025-409.00-25.10--CCBI----12/08/2024
2025-62.00-4.00--CMB INT'L SEC----05/11/2024
2025112.007.00--HSBC----15/11/2024
2025-32.00-2.00--JP MORGAN----29/10/2024
2025185.0011.00--ZHONGTAI INT'L SEC----01/11/2024
2025615.0038.00--CLSA----31/10/2024
 
20261,411.0086.00--CITIC SEC----04/11/2024
2026760.0049.00--HAITONG----02/09/2024
2026220.0014.00--MORGAN STANLEY----30/10/2024
2026197.0012.60--CITIGROUP----11/09/2024
20261,417.0087.00--UBS----28/11/2024
20262,042.00125.30--BOCOM----29/08/2024
20262,148.00138.00--NOMURA----28/08/2024
20261,589.00104.00--BANK OF AMERICA----19/12/2024
20261,425.0091.10100.00BOCI----09/07/2024
20261,780.00109.30--CCBI----12/08/2024
20261,733.00106.00--CMB INT'L SEC----05/11/2024
20261,578.0097.0097.00HSBC----15/11/2024
20261,109.0068.00--JP MORGAN----29/10/2024
2026446.0027.00--ZHONGTAI INT'L SEC----01/11/2024
20262,358.00144.00--CLSA----31/10/2024
Remarks:  Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa.
  *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue
  Real time quote last updated: 24/12/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Profit / (Loss) Attributable to Shareholders (K¥)RMB -392,620
%Change182.158%
EPS / (LPS)RMB -0.240
NBV Per Share (¥)RMB 7.631
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.